Severe acute respiratory syndrome coronavirus 2 convalescent plasma versus standard plasma in coronavirus disease 2019 infected hospitalized patients in New …
E Bennett-Guerrero, JL Romeiser, LR Talbot… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: Four peer-reviewed publications have reported results from randomized
controlled trials of convalescent plasma for coronavirus disease 2019 infection; none were
conducted in the United States nor used standard plasma as a comparator. To determine if
administration of convalescent plasma to patients with coronavirus disease 2019 increases
antibodies to severe acute respiratory syndrome coronavirus 2 and improves outcome.
DESIGN: Double-blind randomized controlled trial. SETTING: Hospital in New York …
controlled trials of convalescent plasma for coronavirus disease 2019 infection; none were
conducted in the United States nor used standard plasma as a comparator. To determine if
administration of convalescent plasma to patients with coronavirus disease 2019 increases
antibodies to severe acute respiratory syndrome coronavirus 2 and improves outcome.
DESIGN: Double-blind randomized controlled trial. SETTING: Hospital in New York …
